James Karrels - Feb 7, 2025 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
SVP, CFO and Secretary
Signature
Beth A. Smith, Attorney-in-fact
Stock symbol
MGNX
Transactions as of
Feb 7, 2025
Transactions value $
-$10,039
Form type
4
Date filed
2/11/2025, 08:30 PM
Previous filing
Mar 6, 2024
Next filing
Feb 19, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise +10K +5.83% 181K Feb 8, 2025 Direct F1, F2
transaction MGNX Common Stock Tax liability -$10K -3.86K -2.13% $2.60 178K Feb 8, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Employee Stock Option (right to buy) Award $0 +113K $0.00 113K Feb 7, 2025 Common Stock 113K $2.60 Direct F3
transaction MGNX Restricted Stock Unit Award $0 +19K $0.00 19K Feb 7, 2025 Common Stock 19K Direct F4
transaction MGNX Restricted Stock Unit Options Exercise $0 -10K -33.34% $0.00 20K Feb 8, 2025 Common Stock 10K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 8, 2024 the reporting person was granted 30,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.
F2 Owned jointly with reporting person's wife.
F3 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
F4 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.